Merck Life Science A/S: Financial statements 2014
CVR: 20830131
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 27,527,082 and a net result of DKK 3,885,492 compared with DKK 4,236,623 the year before. That is an increase of 6% compared with the year before. Equity in the 2014 report amounted to DKK 28,097,650. The solvency ratio was 59.3%.
- Gross Profit
- DKK 27,527,082
- Profit/Loss
- DKK 3,885,492
- Equity
- DKK 28,097,650
- Total Assets
- DKK 47,370,241
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 27.5M | 3.9M | 28.1M | - |
| 2013 | - | 26M | 4.2M | 24.2M | - |
| 2012 | 25.8M | 17.1M | 4.3M | 20M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 8, 2014, KPMG P/S has been appointed auditor of Merck Life Science A/S.
As of September 8, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2013. Gross profit came to DKK 25,961,931, and the net result was DKK 4,236,623.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.